MIDTERM ish Flashcards

filler of not known terms after searching quizlet

1
Q

Is CO2 (carbon dioxide) and acid or a base

A

Acid; H2O is its counterpart (base)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

is NH4 (ammonium) an acid or a base

A

Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

is HCO3 (bicarbonate) an acid or a base

A

Base

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

is H+ (hydrogen) an acid or a base

A

Acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Kidneys regulate secretion and resorption of

A

H+ (acid) and HCO3 (base)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How does hyperventilating affect CO2 levels

A

Increases the amount of CO2 exhaled, raising the pH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

difference between hyperventilating, hypoventilating, and Kussmaul breaths; and how does each affect CO2 levels?

A

hypoventilating (slow, shallow breaths): the body produces more CO2 than it can eliminate causing an increase in CO2 in the body, lowering the pH
Kussmaul breaths (fast, deep breaths; a form of hyperventilating): the body is purposely trying to rid the body of excess CO2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

normal range of PaCO2

A

35 to 45 mm Hg
Rise in CO2 = blood O2 decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal range of HCO3

A

22 to 26 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolic Acidosis

A

(ketoacidosis)
pH: below 7.35
PaCO2: normal (38 to 42 mm Hg)
HCO3: <22 mEq/L $

Increased H+ (hydrogen) / decreased HCO3
Kidneys compensation: retain HCO3, resorption to attempt to raise pH; secretion of H+
Lungs compensation: hyperventilate

Causes: prod./ingestion of acids, renal failure, loss of alkali

Signs: Rapid, deep breaths (Kussmaul); Increased HR; fatigue

Tx: bicarbonate to raise pH;

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Respiratory Acidosis

A

pH: below 7.35
PaCO2: > 45 mmHg $
HCO3: increase 1-3.5 mEq/L for every 10 mmHg CO2 (acute - chronic)

Kidneys compensation: increase production of HCO3; acid in urine
Lungs compensation: Hypoventilate

Signs: Hypoventilation; Abdominal distention, evidence of hypoxia

Tx: treating the underlying illness; use suction to remove mucus from the airway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Metabolic alkalosis

A

pH: above 7.45
PaCO2: Normal
HCO3: > 26 mEq/L $
Kidneys compensation: excrete HCO3 or conserve H+
Lungs compensation: hyperventilation or hypoventilation

Causes: excess loss of acids, HCO3 retention, ingestion of alkali

Signs: numbness, prolonged muscle spasms, nausea

Tx: treat the underlying condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Respiratory alkalosis

A

pH: above 7.45
PaCO2: <35 mmHg $
HCO3: Normal

Kidneys compensation: decreasing production of HCO3 and decreasing acid in urine; acid retention
Lungs compensation:

Signs: hyperventilation; excessive exhalation of CO2

Tx: supplemental O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name the chemicals in constant acid-base equilibrium

A

CO2, H2O, HCO3, H+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

edema

A

clinical manifestation: accumulation of interstitial fluid. Presentation in the extremities is more notable and palpable; however, presentation in the lungs may cause shortness of breath

Tx: typically diuretics are used to aid in elimination of fluid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

hyponatremia

A

Low sodium

Labs: <135 mEq/L

Causes: fluid loss from vomiting and diarrhea or other GI depletion, or an effect from (diuretics); renal dysfunction, adrenal insufficiency (i.e., Addison disease), syndrome of improper ADH secretion, or diabetic ketoacidosis

Signs/symptoms: decreased serum osmolality, headache, anxiety, nausea, hypotension, tachycardia, anorexia, muscle cramps

Tx: focus on underlying etiology, intake/ouput monitoring,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hypernatremia

A

High sodium

Labs: >145 mEq/L

Causes: increased output or decreased intake of water; excessive intake of sodium, diarrhea, burns, and heat stroke

Signs/symptoms: increased serum osmolality, hypotension, tachycardia, dry skin/mucus membranes, headache, decreased skin turgor

Tx: intake/ouput monitoring, nurse lookout for fever or thirst; increase fluid intake if PT excess water output (diabetes insipidus) - synthetic ADH is warranted … seizure watch

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

isotonic

A

solutions have the same osmolality as body fluids.
Normal saline (0.9% sodium chloride) is an example.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

hypotonic

A

the extracellular fluid (ECF) has a lower osmolarity than the fluid inside the cell; water enters the cell
example of a hypertonic solution is 3% sodium chloride.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

hypertonic

A

the extracellular fluid has a higher osmolarity than the fluid inside the cell; water leaves the cell
example of a hypotonic solution is 0.45% sodium chloride.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

hypervolemia

A

Isotonic fluid volume excess typically results from ECF volume excess; increase in ECF sodium

Cause: a decreased excretion of water and sodium, as in acute kidney injury or chronic kidney disease

Clinical manifest: weight gain, decreased hematocrit, dilution of plasma

Signs: distended neck veins, increased BP, and increased capillary hydrostatic pressure contribute to presence of edema.

Tx: restricting fluid intake and correcting the underlying etiology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

hypovolemia

A

Isotonic fluid volume deficit; Normal sodium levels

Causes: hemorrhage, vomiting, diarrhea, fever, excess sweating, burns, diabetes insipidus, and uncontrolled diabetes mellitus

Clinical manifest: decrease in urine output, weight loss, and an increased hematocrit.

Signs: tachycardia, decreased skin turgor and blood pressure, and, potentially, hypovolemic shock

Tx: addressing the cause of the fluid deficit and replacing lost volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

RAAS

A

renin-angiotensin-aldosterone-system

responds to low blood pressure and low serum sodium

Ex:
decrease in BP will stimulate the secretion of renin and subsequent activation of RAAS, resulting in sodium retention, increased fluid volume and BP increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

renin

A

controls production of aldosterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
aldosterone
mineralcorticoid hormone synthesized and secreted by adrenal cortex, in response to hemodynamic changes helps control the balance of water and salts in the kidney by retaining sodium in and releasing potassium from the body
26
decreased/increased serum osmolality
low serum osmolality will suppress the release of ADH, resulting in decreased water reabsorption and more concentrated plasma increase of only 2% to 3% in plasma osmolality will produce a strong desire for thirst
27
hyperchloremia
High chloride ions Labs: Causes: Signs/symptoms: Tx:
28
obstructive shock
caused by an obstruction of blood flow least common for nurse to encounter in ICU
29
cariogenic shock
failure of hear to pump
30
distributive shock
abnormal redistribution of blood types: anaphylactic, septic, neurogenic
31
hypovolemic shock
low blood volume
32
septic shock
(or anaphylatic shock) due to inflammatory vascular response a type of distributive shock = most common in ICU
33
sepsis (general)
the bodys extreme response to infection; can lead to tissue damage, organ failure, and death
34
all shock types (etiology)
development of acute circulatory failure resulting in hypotension and inadequate tissue perfusion; heart failure, low blood volume, redistribution of ECF to extravascular sites, and obstruction of blood flow OUTCOME: poor tissue perfusion
35
perfusion
flow rate of blood through capillaries and extracellular spaces, responsible for transport of O2, nutrients, and waste
36
hypoperfusion (clinical manifestation)
cold, clammy skin (a result of vasoconstriction and cyanosis), renal output decrease (oliguria), confusion (obtundation), hyperlactatemia, and hypercoagulability
37
oliguria
production of abnormally small amount of urine
38
hypovolemic shock (cause)
loss of >15% of body fluid severe dehydration, inadequate ECF, sig. blood loss, excess vomit/diarrhea, MODS, burn injury
39
cardiogenic shock (s/s)
decreased CO (cardiac output), MI, HF, cardiac tamponade, restrictive cardiomyopathy, constrictive pericarditis, MODS
40
obstructive shock (s/s)
clinical : disturbance of consciousness, oliguria, hypotension, and tachycardia obstruction of major blood vessels, obstruction of cardiac pumping, cardiac tamponade, pulmonary embolism, MODS
41
distributive shock (s/s)
clinical : imparied distribution of blood flow, extensive vasodilation, loss of vascular tone, septic shock, anaphylactic shock, neurogenic shock, MODS
42
sepsis (s/s)
43
hemodynamics (factors that influence circulation)
blood volume, systemic vascular tone, heart rate, force of contraction
44
MODS
multi-organ dysfunction syndrome
45
stage 1 shock
early, reversible, compensated sympathetic activation cause tachycardia and vasoconstriction kidneys respond with active RAAS to reabsorb sodium and water to maintain fluid strong chance of recovery
46
stage 2 shock
intermaediate, progressive compensation begins to fail, decrease in persuion = hypoxia PT experience confusion, disorientation, angina (d/t decreased O2 delivery to myocardium), muscle pain reversible if right treatment is implemented promptly
47
stage 3 shock
refractory, irreversible permanent toll on body and organs heart func. decline, kidneys shutdown, cells = hypoxia and cell death PT death due to MODS
48
qSOFA
(Quick Sequential Organ Failure Assessment) bedside diagnosis criteria for septic shock (altered mentation) Glasgow coma scale <10, systolic BP of 100mmHg or less, and respiratory rate of 22/min +
49
Neurogenic shock
blockage of sympathetic nervous system outflow to the intrathoracic sympathetic chain caused by any factor that increases parasympathetic stim common in spinal cord injury above T6, 2nd to parasym. outflow from T1-L2 more severe = higher on spinal cord
50
neurogenic shock (s/s)
decrease in vascular resistance, loss of vascular capacitance with assoc. vascular dilation and bradycardia in the absence of hypovolemia hypovolemia = tachycardia Clinical : systolic hypotension, bradycardia, hypothermia
51
SOFA
evaluates multiple different systems (cardiovascular, respiratory, coagulation, renal, hepatic, neurologic) predicting potential mortality and can guide clinical intervention
52
anaphylactic shock (s/s)
stridor, tachycardia, dyspnea, wheezing, coughing, edema, laryngospasm, bronchoconstriction, angioedema, urticaria, pruritus, hives, gastrointestinal cramps, and hypotension
53
MODS
multi-organ dysfunction syndrome 2+ system dysfunction; homeostasis in PT cannot be maintained without intervention most commonly caused by septic shock
54
MODS (s/s)
6 primaries (respiratory, renal, hepatic, cardio, gastro, neuro) Renal & hepatic = serum creatinine or bilirubin levels. Hematologic = thrombocytopenia Cardio = changes in blood pressure and the heart Neuro = level of consciousness Gastro = tenderness of abdomin, palpable masses Assessment will focus on Glasgow Coma scale scores
55
ischemia
drop in bloodflow to the brain; a lack of O2 and glucose that lead to tissue dmg
56
hematoma
increasing pressure in the skull (bleeding in tissue or excess prod. of CSF)
57
CSF
(cerebral spinal fluid) choroid plexi produces CSF within ventricles flows in the subarachnoid space surrounding the brain and spinal cord, providing buoyancy and nourishment
58
hydrocephalus
excessive accumulation of CSF in brain can cause increased pressure within skull
59
BBB
(blood brain barrier) specialized endothelium in brain capillaries that permits selective entry of substances Highly lipophilic subs are able to cross, H2O by diffusion and most others by facilitated diffusion
60
cerebral autoregulation
critical to providing a steady flow of O2 and nutrients to brain and removing metabolic waste; maintains blood flow to brain and spinal cord despite fluctuation in mean arterial pressure
61
cerebral blood flow
blood supply to the brain in a given time
62
intracranial pressure
pressure exerted by contents of cranium: brain tissue, blood, and CSF
63
TIA
(transient ischemic attack) temporary episode of neurologic dysfunction cause by focal brain, spinal cord, or retinal ischemia without acute infarction cause : clot that blocks bld supply to brain; does not cause permanent damage buildup of fatty deposits on arterial walls (atherosclerosis)
64
TIA (s/s)
facial drooping, extremity weakness (esp. one sided), speech difficulty, sudden trouble seeing, difficulty walking with dizzy, lack of balance, severe headache unkown cause
65
TIA (Tx)
(w/in 24-48hrs) urgent evaluation, risk stratification, and PT education of stroke prevention therapy
66
TIA mimics
hypoglycemia, seizure, intracranial hemorrhage
67
stroke
interruption in bld supply to brain or bleeding vessel that results in brain tissue dmg or infarction
68
ischemic stroke
partial or complete occlusion od cerebral bld flow to an area of the brain d/t a thrombus or embolus athersclerosis = most common lead (conditions = increased risks pg. 672)
69
thrombotic stroke
occlusion of bld vessel as a result of plaque buildup along vessel wall, usually involve internal carotid, mid-cerebral, or basilar artery
70
hemorrhagic stroke
bleeding in brain d/t bursted bld vessel (intraparenchymal) intracerebral = bld in brain tissue (parenchyma) intraventricular = bld in ventricles extracerebral = bld in membrane surrounding brain
71
aneurysm
abnormal bulge along vessel wall that fills with bld and is caused by a weak or thin area of wall symptoms occur when it puts pressure on brain or it leaks/ruptures causing a hemorrhage
72
AVM
(arteriovenous malformation) tangle of abnormal/poorly formed bld vessels can occur anywhere and are at the greatest risk of bleeding Dural AVM = acquired disorder (usually trauma)
73
AVM (s/s)
(would be considered a stroke) sudden onset of neurologic deficit that lasts 24hr and is due to a reduction or occlusion of cerebral circulation or rupture of blood vessels s/s : fig. 27.3
74
ischemic stroke (Tx)
restore bld flow and reduce area of infarction (brain tissue death); area surrounding the infarction (penumbra) can be salvaged if perfusion is restored quickly Acute stroke : O2 is used to improve oxygenation, glycemic control to norm rng, and BP managed for adequate perfusion
75
DCI
(delayed cerebral ischemia) neurologic deficit, cognitive deficit, or both that occur in 3-14 days after hemorrhage
76
hemorrhagic stroke Tx
priority of care = ventilation and BP management osmotic dieuretics = decreased intrcranial pressure
77
subdural hemorrhage
bleed from the bridging veins below inner layer of dura (between dura mater and arachnoid membrane) does not directly occlude bld vessels, so is not considered a stroke; can become large enough to cause a stroke though
78
subdural hemorrhage (s/s)
headache, confusion, behavior change, dizziness, nausea, vomiting, lethargy, weakness, apathy, seizures size of hemorrhage and age of PT affect response
79
subdural hemorrhage (Tx)
surgery must be considered before surgery, ventilation and BP are priority
80
spinal cord hemorrhage
rare but may occur with trauma, vascular malformation, or bleeding disorders (epidural, subdural, subarachnoid, or intramedullary) intramedullary = bleed in white + gray matter epidural/subdural = compression on spinal cord
81
spinal cord hemorrhage (s/s)
sudden, severe, localized back pain with or without radiculopathy intramedullary = hemiparesis, paraparesis, or quadriparesis; sensory loss below the lesion; and loss of sphincter control
82
hemiparesis
weakness or inability to move one side of body
83
paraparesis
partially unable to move legs
84
quadriparesis
(tetraparesis) muscle weakness in all four limbs
85
tetraplegia
inability to move upper and lower body
86
spinal cord hemorrhage (Tx)
surgical resection for decompression or catheter-based intervention, raditation therapy (photon or gamma knife)
87
HF
(heart failure) inability of heart to pump adequate bld to meet bodys metabolic needs
88
HF (causes)
muscular contraction = decreased ejection muscular relaxation = heart not filling adequately combo
89
HF (s/s)
fatigue, SOB, inability to exercise, extremity edema, death
90
CO
(cardiac output) amount of bld pumped out of heart in L/min
91
RAAS (response to CO)
if CO decreases = RAAS & SNS are activated fluid retention and vasoconstriction
92
left side HF
left = responsible systemic circulation; failure results in vol. overload & venous congestion in lungs s/s : fatigue and SOB; decreased CO = RAAS & SNS active = bld volume increase = pulmonary congestion = dyspnea pulmonary congestion = right side works harder against the pressure and may fail as a result
93
right side HF
right = responsible lungs circulation; failure results in systemic venous congestion = elevated jugular ven. pressure, hepatic congestion, peripheral edema *everything behind the failure gets backed up*
94
systolic failure
HF with reduced EF amount of bld present at end of diastole (preload) is important
95
diastolic failure
EF is preserved, contractility is preserved or slightly impaired, but muscle relaxtion impaired = inadequte filling, decreased preload = reduced CO impaired fill (bigger issue) = tachycardia + diastolic fill time decreased = even more reduced SV
96
SV
(stroke volume) amount of blood pumped out of heart with each beat in mL
97
EF
(ejection fraction) measurement of percentage of blood ejected from left ventricle with each contraction
98
High output HF
heart still pumping high amount of blood (8L/min); vasodilation + BP decrease
99
Low output HF
(simply HF) CO reduced = decreased perfusion
100
acute HF
isolated event without prior hx rapid prog. to critical illness; MI, myocarditis, drug toxicity PT may suffer chronic HF after Tx : underlyting cause
101
chronic HF
management : low-salt diet, medications, monitor symptoms/vitals, lifestyle decisions (ADHF; acute decompensted HF) chronic HF PT can still develop acute HF = worsening symptoms any stress to the heart can result in decomp. (inf./diet/lifestyle/meds) Tx : hospital and underlying cause to be idetnified and treated
102
NYHA Class 1
does not affect daily activity
103
NYHA Class 2
comfortable resting, but slight limit in activity
104
NYHA Class 3
markedly limited in physical activity, still comfort at rest
105
NYHA Class 4
experience symptoms at any level of activity and sometimes at rest
106
ACC/AHA Stages of HF
Stage A: high risk for HF w/o structural dis or symptoms Stage B: structural dis but w/o s/s of HF Stage C: structural dis w/ prior or current symptoms Stage D: refractory HF requiring specialized interventions
107
Killip Classification
Class I: No heart failure. No clinical signs of cardiac decompensation Class II: Heart failure. Diagnostic criteria include rales, S3 gallop and venous hypertension Class III: Severe heart failure. Frank pulmonary edema Class IV: Cardiogenic shock. Signs include hypotension (systolic blood pressure of ≤90 mmHg) and evidence of peripheral vasoconstriction such as oliguria, cyanosis, and diaphoresis. Heart failure, often with pulmonary edema, has been present in a majority of these patients.
108
systolic HF (cause)
dilated cardiomyopathy (weakening of heart muscle) idiopathic, ischemic (related to Coronary Artery Disease), or genetic CAD w/ MI, diabetes, thyroid, hormonal alcohol or cocaine nutritional deficiencies, chemo
109
Preload
amount of blood in the ventricle before contraction, at the end of diastole affected by: body fluid volume, venous return to heart, and EF (ejection fraction)
110
Afterload
amount of pressure the heart needs to generate to pump blood out of the ventricle the ventricle must contract strongly enough to overcome the blood pressure in that system Reducing afterload typically allows the heart to work more efficiently
111
contractility
strength of muscular contraction in the heart muscle. Greater contractility typically leads to increasing stroke volume
112
SVR
(systemic vascular resistance) resistance to forward flow of blood generated by the blood vessels in the systemic circulation Normal SVR is 800-1200 dynes-sec/cm^5. Low SVR = lower pressure needed to provide fwd flow
113
blood flow through the heart
right atrium > tricuspid > right ventricle > pulmonary valve > lungs > left atrium > mitral > left ventricle > aortic
114
cardiac remodeling
physical hypertrophy of heart muscle, becomes less coordinated with opposing ventricles, less elongated fibers, shorter and more rounded Angiotensin II contributes to promoted hypertrophy
115
systolic HF (s/s)
fatigue, sleep disturbances, weight loss, anorexia, and dyspnea depression and cognitive dysfunction is also common peripheral edema, diminished distal pulses, hypotension, tachycardia, and narrow pulse pres-sure pulmonary edema and hepatic congestion may also develop, manifesting in cough, frothy sputum, and right upper quadrant tenderness or pain.
116
systolic HF (Tx)
reducing symptoms by decreasing fluid retention and counteracting the neurohormonal effects of HF. ACE inhibitors are considered first-line therapy in the treatment of systolic HF.
117
diastolic HF (cause)
stiffnes of hear muscles, abnormal electrolyte movement into and out of the myocardial cells causing failure of the heart muscle to completely relax
118
diastolic HF (s/s)
dyspnea with exercise, more fluid retention in abdomin (PT describe as bloating or fullness)
119
diastolic HF (Tx)
No therapy has been shown to improve survival in patients treat PT according to underlying disease
120
left-side HF (cause)
cardiomyopathy, coronary artery disease, alcohol or cocaine abuse, or hypertension
121
left side HF (s/s)
hypertrpophic heart, increase in pulmonary venous pressure = paroxysmal nocturnal dyspnea, activation of RAAS = increase in preload and afterload reduced CO = hypotension, fatigue, decreased urine output, exercise intolerance, dizziness, syncope, distal pulse decrease, cool skin, tachycardia, BP low, weight loss
122
paroxysmal nocturnal dyspnea
sudden shortness of breath while sleeping
123
orthopnea
difficulty breathing while laying flat
124
left-side HF (Tx)
similar to systolic HF: reversing the effects of the body’s natural responses to the HF, Fluid retention is alleviated by the use of diuretics, RAAS is blocked by the use of ACE inhibitors PT educated to weigh themselves, monitor vitals, and low-sodium diet
125
right-side HF (cause)
typically caused by left-side HF pulmonary HTN (pressure too great for afterlod of right ventricle to pump), ischemia, contractility reduction
126
right-side (s/s)
In right ventricular failure, the left ventricle is inadequately filled, leading to reduced CO. Patients may exhibit s/s of reduced CO, including cool extremities, poor distal pulses, fatigue, exercise intoler-ance, and syncope Patients may complain of nausea, vomiting, and early satiety as the liver enlarges and causes pressure on the stomach, liver function may be impaired elevated jugular venous pressure, distended neck veins, peripheral edema
127
pulmonary vascular resistance
the resistance to flow of blood generated by the blood vessels in the pulmonary circulation
128
right-side HF (Tx)
dependent on underlying cause; help reduce RV afterload and improve RV failure; low sodium diet
129
high output HF (cause)
marked by unusually low SVR and elevated CO; caused by dilation of vascular bed or arteriovenous fistula decrease SVR = anemia (nitric oxide > vasodilation), sepsis
130
arteriovenous fistula
abnormal connection between 1+ arteries and 1+ veins = systemic shunting (caused by): Paget disease, multiple myeloma, liver disease, or an artificially created fistula such as one created for dialysis
131
high output HF (s/s)
similar to systolic, (and right side HF) signs of volume overload such as hepatic congestion, elevated jugular venous pressure, and peripheral edema. Patients may also experience fatigue and dyspnea
132
high output HF (Tx)
treating cause of vasodilation, control symptoms, and support vital functions
133
cardiac index
value obtained when the CO is divided by body surface area
134
CAD
(coronary artery disease) bloodflow to myocardium is reduced sometimes interchangeable w/ (coronary heart disease) buildup of plaque (made of cholesterol) [fatty] deposits in the coronary arteries (atherosclerosis) Dx included with CHD: silent myocardial ischemia, myocardial infarction, angine pectoris, acute coronary syndrome (ACS)
135
angina
(angine pectoris) chest pain, discomfort, pressure, squeezing symptoms of CAD when the heart is not receiving enouhg perfusion blood
136
CVD
(cardiovascular disease) commonly atherosclerosis, causes disease of the heart and coronary and systemic circulation Dx include: stroke, TIA, claudication, and limb ischemia
137
claudication
leg pain that is induced by exercise, typically caused by decreased arterial blood flow
138
myocardial ischemia
restriction or decrease in bld supply to the heart muscle tissues = shortage of O2
139
myocardial infarction
complete occlusion of bld flow leading to cell death, or necrosis athersclerosis > thromboembolism thrombus (blood clot) is carried through the vessel and becomes lodged (embolism)
140
ideal cardiovascular health
w/o cardiovascular disease Life Simple 7: BP, physical activity, cholesterol, diet, weight, smoking habits, blood glucose
141
thrombosis
process of formation of a thrombus that obstructs blood flow to organs depending on where it comes from; when formed in coronary artery, the block can cause an MI
142
vasospasm
a sudden contstriction of a blood vessel that decreases the vessels diameter and thus decreases blood flow
143
aneurysm
a localized, blood-filled, balloon-like bulge in the wall of a blood vessel
144
a name for atherosclerosis that can affect all arteries in the body?
ASCVD (atherosclerotic cardiovascular disease)
145
dysrhythmia
abnormal heart rhythm that can be irregularly slow or fast (aka arrhythmia)
146
coronary angiography
(aka coronary arteriography) invasive procedure that is usually used to confirm the diagnosis of CAD after noninvasive test have been inconclusive
147
coronary perfusion pressure
the pressure of blood through coronary circulation as a result of the pressure gradient between the aortic pressure and the right atrial pressure
148
autoregulation
the phenomenon that maintains the constant regulation of coronary blood flow through the myocardium despite changes in coronary perfusion pressure
149
tachycardia
(abnormal rapid heart rate, generally more than 100 beats per minute)
150
stable angina
occurs with increased myocardial oxygen demand and reduced blood flow during exertion or emotional stress, commonly caused by atherosclerosis
151
stable angina (cause)
gradual narrowing of the arteries: endothelial dysfunction, coronary microvascular disease (MVD), vasospasms
152
stable angina (s/s)
chest discomfort {usual complaint}, may also result as postpandrial (after eating), dyspnea, fatigue, belching same as angina pectoris, sqeezing, tightness, crushing, suffocating, and pressure
153
stable angina (Tx)
stress test (cardio-vascular magnetic resonance (CMR) myocardial perfusion imaging) Beta blockers, ACE inhibitors, or ARBs when ACE are not tolerated short-acting nitroglycerin
154
silent ischemia
higher prevalence being likely for patients with diabetes
155
silent ischemia (cause)
thought to be due to defective anginal warning as a result of an issue with peripheral and neural processing of pain
156
silent ischemia (s/s)
chest pain may not always be present; ST-segment depression may or may not be present
157
IHD
ischemic heart disease
158
silent ischemia (Tx)
tx of symptomatic and asymptomatic ischemia would be similar = nitrates, beta blockers, CCBs (reduce or eliminate episodes) lipid-lowering therapy as secindary
159
MVD (cause)
not currently known, could be d/t ischemic process or other causes such as endothelial and microvascular dysfunction, coronary vaso-spasms, or myocardial metabolism problems
160
MVD
(microvascular dysfunction or coronary microvascular dysfunction) damage to the walls and inner linings of small coronary arteries that can lead to narrowing, spasms, and decreased blood flow
161
MVD (s/s)
angina in the absence of ischemia caused by CAD is a common characteristic, difficult to differentiate from angina with ischemia
162
MVD (Tx)
standard test used to detect CAD do not work for MVD; noninvasive methods: Doppler echocardiography, SPECT scan, and CMR myocardial perfusion imaging, have proved helpful in detecting MVD
163
ACS
(acute coronary syndrome) acute form of CAD; any cluster of clinical signs and symptoms that are related to acute myocardial ischemia and infarction Types: - non–ST-segment elevation acute coronary syndrome (NSTE-ACS), which formerly was known as unstable angina - non–ST-segment elevation myocardial infarction (NSTEMI) - ST-segment elevation myocardial infarction (STEMI)
164
NSTE-ACS
(non–ST-segment elevation acute coronary syndrome) formerly known as unstable angina presents as myocardial ischemia without ST elev. accelerates in frequency and severity but does not result in myocardial necrosis {ischemic}
165
NSTEMI
(non-ST-segment elevation mycardial infarction) myocardial ischemia in the absence of ST elevation on ECG but the presence of elevated biomarkers of myocardial necrosis = acute MI major difference between NSTEMI and unstable angina is the biomarker of necrosis {infarction}
166
STEMI
(ST-segment elevation mycardial infarction) myocardial necrosis more precise term for heart attack {infarction}
167
unstable angina
chest discomfort or pain related to lack of blood flow through coronary arteries and subsequent myocardial ischemia that is less predictable than stable angina and may occur at rest
168
STEMI (cause)
state of heightened inflammation and prothrombotic components adv. atherosclerosis, nonobstructive plaque rupture, embolus exposure to fine particle pollution could increase risk of ACS,
169
atrial fibrillation
dys-rhythmia that may cause pooling and clotting of blood and the risk of embolization if the clot breaks free and obstructs an artery
170
STEMI (s/s)
ischemic nerve endings cause pain, but necrotic myocardium will not angina, dyspnea, malaise (radiate to shoulder, arms neck), fatigue, diaphoresis, palpitations
171
bradycardia
less than 60BPM
172
STEMI (s/s)
ischemic nerve endings cause pain, but necrotic myocardium will not angina, dyspnea, malaise (radiate to shoulder, arms neck), fatigue, diaphoresis, palpitations
173
STEMI (Tx)
ECG alone is not sufficient to Dx a STEMI timely reperfusion and function of caridomyocytes Timely Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a nonsurgical technique for treating obstructive coronary artery disease, including unstable angina, acute myocardial infarction (MI), and multivessel coronary artery disease (CAD) will greatly increase survival chance.
174
automaticity
ability of specialized myocardial cells, or pacemaker cells, to generate an electrical impulse (depo-larize) to regulate the heart rate in accordance to the body’s needs.
175
absolute refractory period
time after the firing of a nerve fiber during which the nerve fiber can-not be stimulated, regardless of the strength of the stimulus applied
176
VF
(ventricular fibrillation) most serious dysrhythmia; has greatest risk of occurence within first hour of MI related to absolute refractory period
177
which electrolyte imbalances have the greatest risk for heart dysrhythmias?
hypokalemia and/or hypomagnesemia
178
ventricular aneurysm
defect in the left or sometimes right ventricle wall in which there is bulging outward dur-ing both systole and diastole, usually as a result of a MI (cause) female, LAD artery occlusion, no Hx of angina (s/s) 3-4 heart sound present, systolic murmur TTE (transthoracic echocardiography) used to identify
179
ventricular septal rupture
type of ventricular septal defect in which there is an abnormal opening between the left and right ventricles causing oxygenated blood (from the left ventricle) to mix with deoxygenated blood (from the right ventricle) as a result of left-to-right shunting.
180
pericarditis
swelling and inflammation of the pericar-dium, the thin double-layered sac surrounding the heart, as a result of injury such as an acute MI, infection, inflam-matory disorder, trauma, cancer, or congenital causes 10% chance to accour 23-96hrs post-MI
181
Dressler syndrome
also known as post-MI syndrome, is the late pericarditis and possibly has an autoimmune pathogenesis
182
pericarditis (s/s)
pleuritic chest pain, pain worsens with deep inspiration, cough, swallow, lying down pericardial friction may rub and be auscultated
183
pericarditis (Tx)
hospitalization for management and OBS of possible cardiac tamponade, aspirin every 4-6hr to reduce inflammation and treat pain
184
cardiac tamponade
life-threatening condition of increased pericardial pressure as a result of blood or fluid buildup between the myocardium and the pericardium
185
cardiac tamponade (cause)
pericardial effusion (fluid accumulation), trauma, inf, cancer, med side effect, HF, MI, raditation, Dressler, PCI, surgery, inflammatory disease
186
cardiac tamponade (s/s)
dyspnea, edema, oliguria (low urine output), jugular venous distention, tachypnea {pant}, and tachycardia
187
cardiac tamponade (Tx)
prompt surgical Tx is needed, MRI can confirm presence, fluid removed and examined to identify cause
188
valvular disorders
problems that disrupt blood flow through the atria and ventricles as a result of abnormal func-tioning of one or more of the four heart valves such as stenosis, regurgitation, or prolapse
189
the four heart valves?
atriventricular: tricuspid and mitral semilunar: pulmonic and aortic
190
valvular disorders (cause)
Increased risk of valvular disorders is associated with age, gender, tobacco use, high cholesterol levels, hypertension, and diabetes
191
regurgitation
leaking valve; not closing completely
192
prolapse
valves don't close smoothly, or overextend into next chamber (balloon)
193
stenosis
hardening or fusion; in the case of mitral valve, may be fused together and restrict blood flow; or could be hardened in an open state and function improperly
194
valve disorder (Tx)
surgical replacement
195
coronary collateral circulation
can develop in the heart as an adaptation to ischemia; as an alternative path for blood supply
196
PVD
(peripheral vascular disease) general term referring to conditions affecting circulation in the tissues other than the brain or heart affects veins; chronic venous insuffi-ciency, deep vein thrombosis, leg ulcers, and varicose veins
197
PAD
(peripheral artery disease) affects arteries, caused by arteriosclerosis
198
arteriosclerosis
thickening, loss of elasticity, clacification of walls of arteries
199
atherosclerosis
build up of plaque within artery that harden and narrow
200
plaque is made of
cholesterol, calcium
201
hyperlipidemia
(form of dyslipidemia) elevated level of blood lipids
202
LDL
(Low-density lipoproteins) primary carriers of cholesterol "Less-Desireable Lipoproteins"
203
HDL
(high-density lipoproteins) help to clear cholesterol from the arteries "highly-desireable lipoproteins"
204
atheroma
region of plaque consists of calcium, macrophages, lipids, and fibrous connective tissue, where atherosclerotic narrowing begins to build up
205
vulnerable plaque
more inflammation and thinner fibrous cap, more susceptible to rupture with subsequent thrombi formation
206
arterial dissection
caused by a tear in the tunica intima in which the blood vessel splits and blood goes between the inner and outer layers, separating the walls trauma, heredity, cocaine use, pregnancy, and hyperten-sion are associated risk factors
207
angioplasty
stent placement is the minimally invasive procedure A balloon-tipped catheter is placed into an artery and advanced to the area of blockage. The balloon is inflated, pressing the plaque against the arterial wall. Once opened, the balloon is deflated, and a small wire mesh tube called a stent is placed in the vessel to keep it from narrow-ing or closing again
208
NAPAD
(Nonatherosclerotic peripheral arterial disease) group of disorders in which blood flow is decreased for reasons other than plaque buildup coarctation of the aorta, thoracic outlet syndrome, and Raynaud disease
209
TOS
(thoracic outlet syndrome) thoracic outlet starts at the base of the neck and goes behind the clavicle, over the first rib, and down the arm If the path is narrowed, it can restrict the flow of blood and nerve function (s/s) poor bld flow or decreased nerve function
210
coarctation
birth defect resulting in narrowing of aorta
211
Raynaud disease
condition characterized by attacks of vasospasm in the small arteries and arterioles in the fingers often triggered by cold weather and emotional stress Primary (idiopathic), secondary (caused by another condition) (s/s) skin devoid of color, cyanotic, numbness, tingling, ischemia may result in ulceration or necrosis
212
Raynaud (Tx)
events may not be severe enough for medical attn. tx for 2nd addresses underlying condition prime med is calcium channel blockers
213
CVI
(chronic venous insufficiency) disorder in which the veins are unable to return adequate blood to the heart long-term disorder that most com-monly occurs as a result of blood clots in the deep veins of the legs, a condition called deep vein thrombosis (DVT)
214
CVI (causes)
genetic predisposition, gender (the disorder is more com-mon in women), pregnancy, age over 50 years, smoking, lack of physical activity, obesity, and occupations requiring long periods of standing or sitting. Use of oral contracep-tives
215
CVI (s/s)
leg cramps and pain that worsens when standing, edema of leg, thickening or discoloration of skin on calves
216
leg ulcers
(CVI is most common cause) sores on the skin that persist for more than 6 weeks and take several months or longer to heal
217
varicose veins
veins that have become enlarged and twisted because of the rupture of valves superficial thrombophlebitis = inflam of varicose veins
218
DVT
(deep vein thrombosis) a thrombus (blood clot) occurs in a vein deep in the body; the thrombus may become an embolism that can travel to the heart, lungs, brain, or other vital organs of the body. (s/s) pressure builds, fluid starts to leak out of the swollen veins, causing edema and additional pain. The area may become reddened, hard, and warm as a result of blood backing up in the area.
219
DVT (Tx)
a positive D-Dimer indicates high amount of fibrin degradation and suggests clot formation Obesity is the main culprit for DVT
220
Elevated BP
120-129 AND < 80
221
Stage 1 HTN
130-139 OR 80-89
222
Stage 2 HTN
>140 OR >90
223
Stage 3 HTN
>190 AND/OR >120
224
essential HTN
(primary HTN) HTN that does not have a known cause 90% of the cases
225
secondary HTN
identifiable and categorized cause
226
hypertensive urgency
patient presents with severe HTN without evidence of organ damage
227
hypertensive crisis (s/s)
myocardial ischemia or infarction. Renal function is diminished, and blood or protein may be found in the urine. Acute renal failure may occur. In the brain, thrombotic or hemorrhagic stroke may occur. The capillaries in the brain become leaky, producing hypertensive encephalopathy (edema of the brain), with symptoms of headache, paralysis, seizures, or coma. Reti-nal hemorrhages and edema of the retina (papilledema) are signs of severe HTN.
228
hypertensive crisis
rare condition that occurs when systolic pressure exceeds 180 and/or diastolic pressure exceeds 120 mmHg. formerly called malignant hypertension or hypertensive emergency Organ damage occurs primarily in the cardiovascular system, kidneys, or brain
229
HTN lifestyle changes
□■Restrict sodium consumption □■Limit alcohol consumption □■Stop smoking □■Maintain an optimal weight □■Reduce intake of saturated fat and cholesterol, and increase consumption of fruits and vegetables □■Increase physical activity □■Reduce stress levels
230
hemostasis
cessation of blood flow, particularly through the action of coagulation related to conditions of excess coagulation or bleeding
231
hemorrhage
copious bleed-ing, which can be outside of the skin (as from a laceration) or in the skin (ecchymoses) bruise
232
ecchymoses
(bruise) bleeding within skin
233
thrombocytes
(platelets)
234
phases of hemostasis
vascular (initiation): constriction of vessels + platelet activation aggregation (amplification): platelet begin to clump and form plug coagulation (propagation): platelet rel. factors = form fibrin = layer over plug to stop blood loss
235
thrombocytopenia
(reduction in number of platelets)
236
primary hemostasis
associated with abnormalities in the number or function of platelets Ex: von Willebrand, a lack of a certain factor prevents platelets from adhering to the site of injury, prevent clot
237
secondary hemostasis
lack of, or reduction in, factors tied to coagulation Ex: lack of factor VIII = hemophilia
238
hereditary hemostasis
vWD and hemophilia
239
aquired hemostasis
liver disease and vitamin K utilization
240
thrombocythemia
an excess of platelets can lead to spontaneous blood clot formation
241
bleeding precautions
Patients who are at risk of excessive bleed-ing need to be educated about their condition and provided with instructions about preventing bleeding. soft toothbrush, wearing shoes at all times, avoiding contact sports, and using stool softeners to prevent straining
242
intrinsic factor pathway
XII > PF3 > VIII & IX > X
243
extrinsic factor pathway
III > VII > X
244
common pathway
X > Prothrombin activator > Prothrombin > Thrombin > Fibrinogen > Fibrin
245
hematopoiesis
the process behind the formation of blood cells
246
megeakaryocytopoiesis
(aka thrombocytopoiesis) formation of thrombocytes, reflecting their emergence from megakaryocytes
247
vWD
(von Willebrand Disease) most common bleeding disorder; a lack of a certain factor prevents platelets from adhering to the site of injury, prevent clot 1% population, M&F
248
type 1 vWD
70–80% of all cases of the disease and is characterized by either a failure to manufacture the factor or an increase in clearance
249
type 2 vWD
binding ability of the factor is either significantly enhanced or delayed, resulting in functional deficits
250
type 3 vWD
more severe form in which there is a complete absence of production of the factor
251
D-dimer
measures a fragment of fibrin degradation
252
aPTT
(Activated partial thromboplastin time) Measures the same parameters as PTT but with the addition of a clotting activator to enhance the speed of clotting. This results in a test that is seen as more sensitive
253
PTT
(Partial thromboplastin time) Measures the effectiveness of factors I (fibrinogen), II (prothrombin), V, VIII, IX, X, XI, and XII
254
PT
(Prothrombin time) Measures the functional ability of the extrinsic clotting pathway. Examines factors II (prothrombin), V, VII, and X and fibrinogen
255
vWD (s/s)
varies per type and blood type type 1: asymp.; becomes apparent during surgery = excess bleeding type 3: similar to hemophilia, life-threat + internal bleed
256
Tx for spontaneous bleeding episode
DDAVP (desmopressin) and transfusion with plasma-derived vWD products
257
thrombocytopenia
norm platelet range : 150,000-450,000 /muL increased bleed occurs : 80,000-100,000
258
thrombocytopenia (causes)
artifact, deficient prod.; increased destruction, consumption, or both pseudothrombocytopenia = use of anticoagulant
259
HIT
(heparin-induced thrombocytopenia) type 1 : modest transient decrease in platelet count within the first 2–3 days after initiation of heparin therapy type 2 : (heparin-induced thrombocytopenic thrombosis or white clot syndrome) antibodies to platelet factor IV on the heparin complex. It is seen about 4–14 days after initiation of heparin therapy
260
ITP
(immune thrombocytopenic purpura) autoimmune disease that causes increased destruction of platelets
261
TTP
(Thrombotic thrombocytopenia purpura)
262
purpura
bleeding associated with thrombocytopenia is usu-ally mucocutaneous in nature—on the skin in the form of tiny pinprick hemorrhages or bruises
263
TTP (s/s)
(1) microangiopathic hemolytic anemia (2) thrombocytopenia (3) renal insufficiency (4) fever (5) mental status changes that can wax and wane
264
TTP (Tx)
plasmapheresis = cornerstone of therapy, slowing the destruction of platelets
265
hemophilia
hereditary bleeding disorder resulting from the loss of select clotting factors 2 forms: A&B Male; carrier females have a 50% chance to pass on
266
hemophilia A
a lack of factor VIII
267
hemophilia B
a deficiency in factor IX
268
hemophilia (Tx)
episodic home administration of factor deficient concentrates
269
DIC
(Disseminated intravascular coagulation) life-threatening condition in which the proteins that control clot-ting become overactive; individual faces an increased risk of hemorrhage. (s/s) increased tissue ischemia and bleeding
270
DIC (cause)
sepsis, shock, trauma Dmg to blood vessels and tissue and inflammation can lead to an increase in the concentration of a protein known as tissue factor
271
DIC (s/s)
formation of numerous clots, organ dysfunction DVT or pulmonary embolism testing is critical dyspnea, hemoptysis, SOB, tachycardia, hypotension
272
DIC (Tx)
evaluation of vital signs, assessment of intake and output, and monitoring circulatory status for either the obstruction of blood flow or the presence of hemorrhage determine underlying cause
273
what presents similarly as DIC
thrombocythemia (excess platelets = numerous clots)
274
anemia
characterized by a reduction in the number RBCs or a decline in the ability of erythrocytes to carry oxygen
275
erythrocytes
RBC
276
Hb
(hemoglobin)
277
polcythemia vera
excess of RBCs blood is more viscous = decrease in flow of blood = depriving organs of O2
278
anemia (cause)
1) decrease in prod of erythrocytes 2) reduction in survival time of erythrocytes 3) loss of erythrocytes d/t acute/chronic blood loss 4) func. change in structure of erythrocytes
279
MVC
(mean corpuscular volume) Changes in erythrocyte size; this reflects average RBC size HCT/number of cells in blood
280
fL
(femoliters) unit of measurement equal to 1mm^3; reported value of MVC norm: 80-100
281
HCT
(hematocrit) the proportion of red blood cells in a volume of blood
282
microcytic/macrocytic anemia
presence of small or large erythrocytes micro: cells are smaller than normal, generally as a result of lack of mat-uration time or lower levels of iron macro (megablastic): cells that are larger than normal, generally because of a lack of certain nutrients necessary for successful (DNA) replication
283
MCH
(mean corpuscular hemoglobin) Cell color is determined and reported in picograms norm: 27-34 pg
284
hypochromic
Cells with a lower amount of hemoglobin appear washed out and pale
285
normochromic
Cells that resemble the normal cell color normochrom. anemia = decreased in cell number through blood loss or premature destruction
286
folic acid
B vitamin that is necessary for cell maturation and DNA repair
287
thalassemia
a group of genetic disorders that affect hemoglobin
288
aplastic anemia
reduction in number of stem cells present
289
erythropoietin
hormone commonly provided in the clinical setting as a pharmacologic therapy to aid in the treatment of anemia (hemolytic anemia = destruction of RBC)
290
anemia risk factors
(1) patients with nutritional deficits (iron and B vitamins) (2) patients with intestinal disorders preventing the ability to absorb nutrients (3) patients with chronic health problems (4) patients who are pregnant (5) patients who are experiencing gastrointestinal bleeding (6) patients who have genetic risks such as those with sickle cell disease
291
anemia (s/s)
decreased O2 can lead to muscle weakness, headaache, dizziness (not enough O2 to brain), pallor, tachycardia, hypotension, increased respirations,
292
anemia (Tx)
blood transfusions, replacement of iron or B12, stim factors to promote maturation of RBCs
293
iron deficiency anemia
occur through either a reduc-tion in dietary iron or a loss of iron loss of iron most commonly occurs through hemorrhage, menstrual blood loss in females, and gastrointestinal bleeding in males and females
294
cobalamin deficiency
(vitamin b12) Intrinsic factor is a necessary step in the utilization of cobalamin; changes in the release or absorption of this factor can have adverse effects on red blood cell function. most common cause: pernicious anemia
295
Folic Acid Deficiency
Folic acid works in conjunction with cobalamin, and in its absence, a macrocytic anemia can result
296
folate
B vitamin that is essential for maintenance of DNA
297
SCD
(sickle cell disease) cluster of autosomal recessive disorders that results in misshapen forms of hemoglobin that resemble a sickle or crescent in shape individual has inherited a mutated form of hemoglobin referred to as hemoglobin S (HbS) from both parents chrom 11
298
SCD (s/s)
ischemia anywhere in body, resulting in pain, swelling, tenderness, rapid respiratory rate, HTN chronic tissue hypoxia and tissure dmg
299
SCD (Tx)
prevention, screening, sup-portive care, disease-modifying strategies, and curative procedures O2 supp, blood transfusion, chronic pain management (vaso-occlusive crisis) opiod analgesics
300
thalassemia (cause)
a defect in production of one or more of the globin chains. Hemoglobin comprises four protein chains: a set of two alpha chains and two beta chains alpha: mutation occurs on chromosome 16 beta: mutation of a gene on chromosome 11 is the causative agent
301
thalassemia (s/s)
Growth retardation and cognitive deficits, often identified in early infancy jaundice
302
aplastic anemia (cause)
immune-mediated attack: Activated T cells lead to a process of apoptosis (programmed cell death) within the bone mar-row. These apoptotic processes result in a relative deple-tion of both immature and stem cell populations within the bone marrow.
303
ACD
(anemia of chronic disease) aka anemia of chronic inflammation patients with chronic disease, being associated with inflammatory infectious processes such as infection, chronic immune activation, or malignancy
304
normocytic
the cell size is within the normative range
305
hypoproliferative
number of RBCs are reduced
306
ACD (cause)
iron is a necessary nutrient for bacterial growth, in ACD the body is attempting to deplete iron so not to feed the bacteria
307
ACD (s/s)
generally mild, tired, SOB; no differnt from other anemic forms
308
ACD (Tx)
focused on chronic condition underlying disease as ACD is an adaptive response
309
Polycythemia vera
disorder of the bone marrow in which too many red blood cells are produced; white blood cells and platelets may increase as well primary (absolute): increase in the production of erythrocytes on the part of bone marrow (myeloproliferative) secondary: genetic modifications related to the production of erythropoietin
310
polycythemia vera (s/s)
headache, dizziness, and blurred vision associated with the increased blood volume, increased preload = HTN, blood viscosity = blood clots
311
polycythemia vera (Tx)
anitcoagulation to prevent thrombi, blood-letting to reduce RBC amount and dilute concentration
312
benign
grwoths that contain nonmalignant cells
313
malignant lung tumors (cause)
smoking (responsible for 80-90%) - cigarettes - cigar/pipe - weed/cocaine - 2ndhand smoke - occupational exposure - genetics - benign chronic lung conditions - viral inf - diet - gender : women more susceptible to carcinogen
314
Adenocarcinoma
most common form of lung cancer more common in F than M
315
large cell carcinmoa aka...
undifferentiated tumors, least common form of NSCLC (Non–small cell lung cancer)
316
lung cancer (s/s)
persistent cough w/ or w/o sputum, (cough is usually attributed to smoking, COPD, respiratory inf) blood in sputum, recurrent pneumonia or bronchitis, dyspnea, chest pain, hoarseness, and paraneoplastic syndromes (adv lung cancer)
317
NSCLC (Tx)
Clinical staging is based on the tumor size (T), location of cancer in lymph nodes (N), and metastases (M) stage 0-1 : surgery stage 2-4: surgery is performed, radiation and/or chemotherapy
318
SCLC (Tx)
surgery typically is not indicated multiple chemotherapeu-tic agents and radiation untreated survival = 2-4 months
319
TB
(tuberculosis) primary TB infection: M. tuberculosis organisms have seeded areas in the lung but have not caused significant tissue damage (s/s) : fever and pleural effusion are infrequent disease tuberculosis: clinically significant tissue damage has occurred and the infection is contagious
320
risk factors of TB
□■HIV/AIDS □■Foreign immigration □■Low income, homelessness, and/or malnourishment □■Residing in crowded urban conditions □■Incarceration □■Ethnic minorities (e.g., Hispanics, African Americans, Asians) □■Old age □■Chronic disease (e.g., diabetes mellitus, chronic lung disease, Hodgkin disease, chronic renal failure, alcohol-ism, immunosuppression) □■Currently smoking cigarettes
321
TB (causes)
in US, primary transmitted between infected person and susceptible person via inhalation of aerosolized droplet
322
secondary TB
reactivation of latent TB
323
TB (s/s)
cough, weight loss and anorexia, fever, night sweats, dull aching chest pain, and hemoptysis,
324
TB (Tx)
10 meds; 2-7 months
325
BCG
(bacillus Calmette-Guérin) vaccine that provides immunity to TB
326
dimorphic fungal infection
endemic to particular geo-graphic areas and cause primary infections in both healthy and immunocompromised individuals.
327
histoplasmosis
caused by inhaling spores of Histoplasma capsulatum, is endemic to the Ohio, Missouri, and Mississippi; Caribbean and Central and South America
328
Coccidioidomycosis
(San Joaquin Valley fever) caused by Coccidioides immitis, which is endemic in the soil in the southwestern United States but can be found throughout the world grows best in bird feces
329
Blastomycosis
caused by Blastomyces dermatitidis, an uncommon fungus that is found in Ohio, the Great Lakes region, and the Mississippi; common in dogs, horse, bats, and cows pulmonary granulomas
330
fungal inf (s/s)
competent immune systems: asymp and discovered incidentally immunocompromised: cough and fever plus hemoptysis, dyspnea, and chest pain, weight loss, and hepatosplenomegaly
331
URI
(upper respiratory tract infections) acute infection of one or more structures of the upper respi-ratory tract, including the nose, paranasal sinuses, pharynx, larynx, trachea, and bronchi
332
URI increased risk
very old or very young malnourished = alcoholics cigarette smoke COPD, CF Impaired immune status (HIV, immunosuppressive therapy)
333
URI (cause)
most are passde between human contact
334
URI (s/s)
rhinorrhea (profuse, watery discharge from nose), cough that may or may not be productive, localized mucosal edema with erythema (redness)
335
URI (Tx)
increase the individual’s comfort as well as treating the specific cause of the infection rest, increased fluids to dilute respiratory secretions and replace fluid loss, and antipyretics for systemic symptoms, lozenges, antihistamines
336
croup
(laryngotracheobronchitis) acute viral infection of the upper respiratory tract commonly caused by parain-fluenza viruses that spread among children younger than 5 years of age acute inflammation of the larynx and trachea, narrowing obstructs breathing upon inhalation, wheezy, hoarse cough, fever, dyspnea, and restlessness s/s improve within 3-4 days Tx: moisture and nebulized bronchodilators
337
Epiglottitis
rapidly progressive inflammation of the epiglottis and adjacent structures that is usually caused by bacterial infection, most commonly Haemophilus influen-zae type b (Hib) peaks in children at 3 y/o; but incidence has decreased with infant vaccination
338
acute bronchitis
very common, self-limited lower respiratory tract inflammation, that is often referred to as a “chest cold.” can occur at the same time as a URI or follow one. Acute bronchitis is most often diagnosed in children younger than 5 years of age
339
acute bronchitis (s/s)
broncial inflammation w/ mucousal congestion cough lasting 10-20 days, can persist longer with pertussis hyperreactivity can last 5-6 weeks
340
pertussis aka
(whooping cough) highly contagious respira-tory infection that is usually caused by Bordetella pertussis common among young adults, outgrew child vaccination immunity (s/s) spasmatic cough that ends in loud inspiratory whoop; inf 6 weeks, cough 3-4months
341
bronchiolitis
inflammation of the bronchioles; similar causation as acute bronchitis increased risk for bronchiolitis in premature infants and children with underlying pulmonary problems recurrent = d/t CF
342
bronchiolitis
Symptoms of fine crackles and expiratory wheezing with deep breaths are similar to asthma symptoms, but asthma is uncommon in children under 2 years of age
343
influenza
highly contagious viral infection that sweeps through a geographic region as an epidemic that lasts 6–8 weeks during the winter months flu + pneumonia = 8th leading cause of death in US
344
those at risk for influenza
children < 5, esp. < 2 pregnant >50 y/o chronic medical cond. care home worker, healthcare worker
345
flu types
Type A: most severe vs B or C
346
antigenicity
ability to stimulate the formation of antibodies Major shifts in antigenicity are associated with epidemics and pandem-ics of influenza
347
flu (s/s)
fever, headache, myalgias, and severe malaise after 1–2 days (photophobia and pain with eye movements can occur early) postinfluenza asthenia (postflu syndrome) can occur
348
flu (Tx)
yearly flu shot is recommended alleviate symptoms if intiated within 48hrs
349
pneumonia
inflammation of the lung parenchyma that is typically characterized by lung consolidation with alveoli filled with exudate
350
HAP
(hospital-aquired pneumonia) not incubating at the time of hospital admission and develops 48 hours or more after hospital admission
351
VAP
(ventilator-aquired pneumonia) develops more than 48–72 hours after tracheal intu-bation
352
HCAP
(healthcare-associated pneumonia) patients who were hospitalized in an acute care hospital for 2 or more days within 90 days of developing the infection, or who resided in a long-term care facility or nursing home at the time of infection.
353
CAP
(community-aquired pneumonia) bacteria or viruses, and bacterial pneumonias frequently follow URIs
354
bacterial pneumo vs viral pneumo
bacterial: consolidation of lung tissue primarily by bacterial exudates within alveoli, but there is very little interstitial involvement viral: interstitial pneumonitis with patchy inflammatory changes in the lung interstitium and septa
355
egophony
increased resonance of voice sounds heard on auscultation Lung consolidation is indicated by these bronchial breath sounds
356
pneuomnia (Tx)
supp O2 in serious cases, may be treated with antibiotics for bacterial inf, antiviral meds for viral
357
PH
(pulmonary HTN) increased blood pressure in the pulmonary arteries may represent disease (pulmonary arterial hypertension) can occur secondary to adv. COPD
358
PH (cause)
increased blood flow d/t septal defects of heart, increased vascualr resistance in response to hypoxemia, inflam that cause vasoconstriction, left side HF, drugs like coke and meth
359
PH (s/s)
dyspnea on exertion, lethargy, and fatigue because the heart is not able to increase cardiac output with exercise left side HF progresses to right ventricular failure, individuals may experience angina or syncope with exercise and develop edema hepatic congestion, jugular vein distention, abdominal pain
360
PH (Tx)
vasodilators, specifically prostacyclin
361
PAH
(Pulmonary arterial hypertension) increased pulmonary arterial resistance in the absence of left ventricular failure or chronic thromboembolism (cause): idiopathic
362
embolus
substance or object that travels via the bloodstream to a blood vessel and subsequently lodges in the blood vessel, creating a partial or complete obstruction
363
embolism
a condition in which an embolus travels via the bloodstream and subsequently lodges in a blood vessel
364
PE
(Pulmonary embolism) an embolus is pumped from the right heart into progressively smaller pulmonary arteries until it wedges in a vessel that is too small for it to pass through
365
those at risk of PE
prior Hx of DVT prolonged immobilization recent surgery pregnancy and 6-12 wks post delivery oral contraceptive older adults CVD active cancer hypercoagulability, burns, HIV, drug abuse
366
PE (s/s)
shortness of breath or dyspnea that is not related to activity; hemoptysis; and chest pain that is worse with a deep breath, cough, eating, or bending. The chest pain is worse with exertion but does not go away with rest.
367
PE (Tx)
thrombolytic therapy to dis-solve the clot, anticoagulation to prevent further clots, and oxygen supplementation
368
pulmonary contusion
bruising in lung tissue from a shock wave of force common in motor vehicle accidents or explosion in young adults; potentially lethal
369
alveloar hemorrhage sydromes
(Goodpasture syndrome and granulomatous vasculitis) autoimmunie disorders that affect lung and kidneys of young white adults cause : idiopathic
370
goodpasture syndrome
uncommon antiglomerular basement antibody disease that targets the lungs and kidneys antibodies initiate inflammation of the basement membranes of alveoli and renal glomeruli (s/s): cough, dyspnea, fatigue, hemop-tysis, and burning on urination (Tx): Treatment includes immunosup-pressant drugs combined with intensive plasmapheresis
371
Wegener granulomatosis
rare systemic vasculitis that restricts blood flow, causing damage that may be limited to the upper and lower respiratory tracts but can involve the kidneys and other organs; ANCAs (Antineutrophilic cytoplasmic antibodies) dmg tissue and intiate inflam (Tx) longer term immunosuppression with cytotoxic agents
372
COPD
(chronic obstructive pulmonary disease)
373
air trapping
during exercise, increased inspiratory volume combined with exhalation through contricted airway leads to air trapping impairs venitlation and gas exchange = lung hyperinflation
374
TV
(tidal volume) Volume of air inhaled and exhaled during one cycle of normal unconscious breathing
375
IRV
(Inspiratory reserve volume) after TV, IRV is the maximal volume of air that can be inhaled take a max deep breath
376
ERV
(expiratory reserve volume) maximal amount of air you can exhale
377
RV
(residual volume) the amount of air still in the lungs after ERV
378
FRC
(func residual capacity) ERV + RV
379
IC
(insp. capacity) TV + IRV
380
vital capacity (VC)
ERV + TV + IRV
381
hyperreactivity
an exaggerated response to a stimulus
382
asthma
chronic inflammatory disorder of the airways characterized by recurrent episodes of reversible airway obstruction and hyperreactive airways
383
risk factors of asthma
genetic atopy (predisposition to develop allergies) females after puberty obesity exposure to allergens, irritants, smoke (maternal smoking)
384
classes of asthma
allergic (extrinsic or atopic): triggered by allergens that are external to the individual; type 1 hypersensitivity nonallergic (intrinsic or nonatopic): generate an inflammatory response that involves IgE
385
asthma (s/s)
- chest tightness/SOB - wheeze - cough that is worse in am/pm - prod. thick sputum strings
386
asthma (Tx)
environmental control, asthma education for patients and families, and bronchodilator and anti-inflammatory medications The gold standard treatment for persistent asthma is inhaled corticosteroids
387
hypercapnia
Air trapping and impaired ventilation produce an increase in retained carbon dioxide
388
hyperinflation
overexpansion of the lungs due to air trapping
389
chronic bronchitis
increase in the thickness of the basement membrane and loss of structural support for small airways = airway fixation
390
Emphysema
irreversible loss of walls between alveoli with no evidence of fibrosis = loss of alveoli results in fewer walls available for diffusion of gases (cause) cig smoking prime
391
pulmonary acini
functional units of the lung in which gas exchange occurs
392
chronic bronchitis (s/s)
defined by a productive cough in the absence of a pulmonary infection on most days for 3 months in 2 consecutive years
393
hemoptysis
expectorationof blood from the airways as a result of an erosion through a pulmonary or bronchial blood vessel wall
394
emphysema
common case: smoker in his 60s who reports increased DOE but has little or no cough or sputum production unless he has a pulmonary infection
395
DOE
(dyspnea on exertion)
396
bronchiectasis
characterized by excessive mucus accumulation leading to irreversibly dilated bron-chi that readily collapse, airway obstruction, and frequent inf congenital = infants and children acquired = children and adults
397
bronchiectasis (s/s)
severe persistent cough with a daily production of tenacious, mucopurulent (mucus and pus) sputum that can persist over months or years Tx: long term antibiotics, bronchial hygiene w/ chest physiotherapy
398
volatile acid
dissociate, forming a gas that is eliminated by the lungs carbonic acid (H2CO3) = volatile
399
nonvolatile
(fixed acids) not gases and therefore cannot be eliminated by the lungs; eliminated by kidneys in urine lactic acid, ketoacids, sulfuric acid, and phosphoric
400
base
an acceptor of H+
401
sodium normal range
135-145 mEq/L
402
potassium normal range
3.5-5.0 mEq/L
403
pKa
the dissociation constant of the weak acid
404
compensation
when the renal or respiratory function return the pH closer to or actually back within the normal range
405
correction
condition responsible for the acid–base imbalance is controlled or no longer present
406
antiport
transport molecule that moves two different electrolytes in opposite directions across a cell membrane
407
symport
transport molecule that moves two different electrolytes in the same direc-tion across a cell membrane
408
simple acid/base imbalance
presence of one type of acid–base imbalance □■Respiratory acidosis □■Respiratory alkalosis □■Metabolic acidosis □■Metabolic alkalosis
409
chvostek sign
when there is increased neuromuscular excitability, the facial nerve causes contraction of the lips, nose, and face on the side that was tapped
410
trousseau sign
(during inflation of BP cuff) if neuromuscular excitability is present, the pressure will result in a carpal spasm of the hand
411
ABG
(arterial blood gas) measure of the pH, PaCO2, PaO2, and bicarbonate in the arterial blood.
412
TCO2
(total CO2) measure of carbon dioxide in the form of HCO3 - ions, H2CO3, and CO2attached to proteins such as hemoglobin, as well as the CO2dissolved in plasma
413
venous blood gases
measure of the pH, PaCO2, PaO2, and bicarbonate in the venous blood
414
BE
(base excess) measure of all bases in the blood, including bicarbonate, phosphate, and proteins such as albumin and hemoglobin
415
mixed acid/base imbalances
2+ types of acid–base imbalances in an individual at the same time
416
ROME
respiratory opposite: pH up / CO2 dwn; pH dwn / CO2 up metabolic equal: pH up / HCO3 up; pH dwn / HCO3 dwn
417
hypochloremic metabolic alkalosis
Cl- deficit due to the loss of gastric fluid results in the next most abundant anion, which is bicarbonate
418
hyperchloremic metabolic acidosis
administration of intravenous fluids containing chloride, can cause metabolic acidosis if the chloride accumulates because the increase in chloride results in increased renal excretion of HCO3 -
419
electrolyte
any substance that dissociates into ions in water
420
Chloride normal levels
95-105 mEq/L
421
Calcium normal levels
4.5-5.5 mEq/L
422
ICF
(intracellular fluid) largest portion of fluid spacing in the body; 63–70% of the total volume
423
ECF
(extracellular fluid) component includes the remaining 30–37% of the fluid volume; 3 categories: intravascular, interstitial, and transcellular sodium is prime cation for ECF
424
intravascular ECF
fluids within blood and lymphatic vessels and includes blood plasma and lymphatic and transcellular fluids K, Mg, Ph, proteins
425
interstitial ECF
fluid in tissues and surrounding the cells; transport nutrients, waste, and gas exchange
426
transcellular ECF
reflects fluid found in defined spaces, such as the cerebral spinal fluid, synovial fluid Na, Cl, HCO3
427
osmosis
flow from less concentrated to more concentrated; movement between ICF and ECF
428
osmolality
amount of solute per kilogram of solution
429
diffusion
higher concentration to an area of lower concentration
430
hydrostatic pressure
pressure of fluids or their properties when in equilibrium
431
colloid osmotic pressure
(oncotic pressure) concentration of proteins, particularly albumin, that gives rise to water-pulling forces of a particular compartment at the arterial end of the capillary, resulting in the movement of fluid to the interstitial space
432
increased hydrostatic pressure (cause)
sodium and water retention, usually results from an increased systemic venous pressure due to HF
433
decreased colloid osmotic pressure
may cause edema,
434
third spacing
class of edema: accumulation of fluid in areas (typically the intestinal space) that normally have no fluid or a minimal amount of fluid Ex: ascites and edema associated with burns
435
RAAS
(renin–angiotensin–aldosterone system) sodium retention, increased fluid volume and subsequent blood pressure increase
436
ANP
(atrial natriuretic peptide) produced by atrial cells released in response to the elevated atrial pressure result-ing from the increased circulating volume, due to sodium retention.
437
BNP
(brain natriuretic peptide) originating from ventricular cells released in response to the elevated atrial pressure result-ing from the increased circulating volume, due to sodium retention.
438
hypernatremia (cause)
increased output or decreased intake of water, increased sodium consumption dehydration, diarrhea, burns, heat stroke diabetes insipidus, isotonic fluid vol. deficit, lack of ADH
439
hypernatremia (s/s)
thirst, fever, dry membranes, hypoten-sion, tachycardia, low jugular venous pressure, and restlessness
440
hypernatremia (Tx)
injection of hypotonic or isotonic fluids diabetes inspidius: desmopressin acetate proper intake output manage. seizure precaution
441
hyponatremia (cause)
loss of fluids (vomit, diarrhea, diuretics), inadequate excretion renal dysfunction (Addison), SIADH, diabetic ketoacidosis
442
hyponatremia (s/s)
neurologic: lethargy, headache, confusion, seizures, and coma possible hypovolemia contributes to symptoms of hypotension, tachycardia, and a deceased urine output
443
hyponatremia (Tx)
Correcting the underlying etiology of the hyponatremia is as important as returning the sodium concentration to within the normal range hypertonic fluids, if mild increase dietary intake,
444
hyperchloremia (cause)
metabolic acidosis (most common), water loss, dehydration, head injury that causes endocrine abnormalities, hypernatremia, severe diarrhea, respiratory alkalosis, and hyperparathyroidism
445
hyperchloremia (s/s)
resemble those of hypernatremia, presenting like dehydration
446
hyperchloremia (Tx)
IV hypotonic fluids, lactated Ringer, sodium bicarbonate, diuretic in line with hypernatremia
447
hypochloremia (cause)
fluid loss (vomiting and/or diarrhea or nasogastric suctioning), elevated bicarbonate level, as in alkalosis, burns
448
hypochloremia (s/s)
Acute fluid volume excess = cerebral edema (confusion and convulsions) headache, weakness, nausea, tetany (muscle spasms), weight gain
449
hypochloremia (Tx)
isotonic or hypertonic fluids, monitor of intake output
450
hyperkalemia (cause)
oversupplementation, renal fail (decreased excretion, tissue trauma and breakdown, hypoxia, acidosis, and insulin deficiency)
451
hyperkalemia (s/s)
muscle weakness, paralysis, and dysrhythmias
452
hyperkalemia (Tx)
intravenous calcium gluconate (counter cariac arrest), Intake and output management, dietary education
453
hypokalemia (cause)
GI loss through suctioning, laxatives, incomplete K replacement
454
hypokalemia (s/s)
elevated blood sugar and elevated serum cortisol elevated BNP, BUN, and creatinine flattened T wave, U wave develop-ment, and cardiac arrest in severe
455
hyperaldosteronism
(cushing disease)
456
hypokalemia (Tx)
correcting underlying disease. , supplementation
457
hypercalcemia (cause)
malignancy, hyperparathyroidism that increases PTH lev-els, immobilization, thiazide diuretics, thyrotoxicosis, and excessive ingestion of calcium and/or vitamin D
458
hypercalcemia (s/s)
Cardiac, musculoskeletal, and neuromuscular effects: fatigue, weakness, lethargy, and possibly nausea
459
hypercalcemia (Tx)
intramuscular calcitonin (serum calcium >17mg/dL), in most PT, IV fluid to dilute serum and enhance renal excretion, corticosteroids
460
hypocalcemia (cause)
renal failure, para-thyroid gland removal, hypoparathyroidism, hypomagnesemia, hyperphosphatemia, hypoalbuminemia, vitamin D deficiency, pancreatitis, alkalosis
461
hypocalcemia (s/s)
Tingling, spasms, tetany, and possibly convulsions, Chvostek, Trousseau, intestinal cramp
462
hypocalcemia (Tx)
IV calcium gluconate & calcium chloride, Vit D supp. dietary education
463
hyperphosphatemia (cause)
both primary and acute care is chronic renal failure other: respiratory acidosis, metabolic acidosis, hypocalcemia
464
hyperphosphatemia (s/s)
correlate with hypocalcemia, both Chvostek & Trousseau, decreased BP and arrhythmias in extreme
465
hyperphosphatemia (Tx)
restriction of diet, Vit D to increase calcium absorbtion = dropping serum phosphorus
466
Hypophosphatemia (cause)
malnu-trition, alcohol withdrawal, heat stroke, respiratory alkalosis, hepatic encephalopathy, major burns, hyperparathyroidism, diarrhea, Vit D deficiency
467
Hypophosphatemia (s/s)
similar to hypercalcemia, RBC and thrombo dysfunc, neuromuscular dys-function, altered mental status, convulsions, excessive bone resorption, and possible respiratory failure
468
Hypophosphatemia (Tx)
oral phosphorus, IV managed with caution
469
Hypermagnesemia (cause)
renal failure, laxatives, burns, trauma, shock, lithium toxicity
470
Hypermagnesemia (s/s)
(danger to cardio ) bradyarrhythmias, tall T wave, widened QRS, prolonged QT interval, atrioventricular blocks, and finally cardiac arrest Hypotension, shallow respirations, decreased deep tendon reflexes, and decreased level of consciousness
471
Hypermagnesemia (Tx)
restriction of any Mg., Intravenous calcium gluconate to reverse neuromuscular systems,
472
Hypomagnesemia (cause)
(most common) excessive alcohol intake hypocalcemia, hypokalemia, decreased albumin level, decreased dietary intake, decreased absorption in the small intestine, GI losses, acute pancreatitis, starva-tion, diuretic therapy, and diabetic ketoacidosis
473
Hypomagnesemia (s/s)
premature ventricular contractions, ventricular tachycardia, ventricular fibrillation, and torsades de pointes (very fast HR) changes in mental status and personality along with nystagmus (eyes make repetitive uncontrol move) and hypertension
474
Hypomagnesemia (Tx)
intravenous magnesium sulfate and usually oral magnesium, supplementation can cause diarrhea, intake output management seizure precautions
475
gene
segment of DNA that codes for prod. of certain protein like a sentence
476
genome
like a book
477
chromosome
double helix is combined with proteins called histones and is compacted to form structures like a chapter
478
genetics
study of gens ans their impact on inheritence and single-gene/chromosomal disorder
479
genomics
study of structure, function, analysis of human genome
480
epigenetics
external mod of DNA that affect gene expression
481
epigenomics
study of chem. compounds that instruct the genomw where and when to be expressed
482
nucleotides
each gene is made of a sequence of these 3 components: phosphate, a deoxyribose, and one of four nitrogenous bases, ATGC
483
alleles
alternative forms of an individual gene
484
Barr body
inactivated X chromosome in each cell
485
central dogma
process of DNA to RNA to protein
486
how many chromosomes in each cell of the body
46
487
mitosis
process of cell division used to create identical copies of a cell
488
gonadal cells contain
23 chromosomes, total
489
meiosis
cell division of sex cells so each cell has one of each chromosome pair begins with a cell w/ 46 chrom. (diploid cell) = 2 sets of cell divisions = 4 daughter cells (haploid cells)
490
somatic cells
this is where mitosis occurs; everything that not a sperm or egg
491
transcription
process of reading a gene, RNA is formed from DNA
492
mRNA
template for protein synthesis
493
tRNA
carries appropriate amino acids to the template mRNA during protein formation
494
rRNA
make ribosomes
495
transcription factors
(regulatory proteins) in order for transcription to begin, these must bind to the promoter region at the beginning of the gene
496
splicing
mRNA transcript needs to go through this process ro become a mature message
497
exons & introns
are the useful part, introns split each exon and are throwaways when splicing begins
498
translation
process of protein synthesis with mRNA directing assembly of a string of amino acids to create a protein product
499
codon
3 nucleotides grouped together; 64 possible codons, only 20 amino acids; more than one codon to each amino acid
500
mutation
grammatical error in gene, varying in severity
501
point mutation
a change in one nucleotide
502
silent mutation
if amino acid is not changed by a point mutation
503
missense mutation
casues a change in amino acid
504
nonsense mutation
little or no protein prod. and almost always results in serious clinical consequences
505
genetic imprinting
differential expression based on the parent from whom the genes are inherited
506
SNP
(single-nucleotide polymorphism) Not all genetic changes among individuals are pathogenic
507
aneuploidy
when the wrong number of chromosomes occurs in pregnancy, the embryo is said tobe affected by
508
chromosome nondisfunction
can cause an embryo to have an extra (trisomy) or missing chromosome (monosomy), which most often can result in an early miscarriage but in some cases can result in a live-born baby
509
mosaicism
the presence of more than one genetic cell line in a person
510
triploidy
embryo with 69 chromosomes
511
down syndrome
trisomy 21
512
penetrance
reduced = not everyone who inherits a mutation will have clini-cal symptoms
513
neurofibromatosis
dominant causes numerous cutaneous lesions
514
pedigree
visualization of several generations genetic disease pattern
515
Marfan
dominant connective tissue disorder that causes pathogenic skeletal, ocular, and cardiac features 38
516
syndrome
refers to a group of signs and symptoms that emerge from a disease state
517
prevelance
the number of individuals of a defined population who already have a disease or condition
518
incidence
number of new cases of a disease or condition within a defined period and defined population
519
public health
science of protecting and improving the health of families and communities through promotion of healthy lifestyles, research for disease and injury pre-vention, and detection and control of infectious diseases
520
mortality
the number of deaths in a given population
521
morbidity
departure from physiologic or psychologic well-being and encompasses disease, injury, and disability
522
EBP
(evidence-based practice)
523
illness
the individual experience that a person has with a disease
524
disorder
disruption of physiologic or psychologic function
525
epidemiology
the study of how disease is distributed in populations and identification of the factors influencing the distribution
526
proto-oncogenes
category of genes: regulate cell proliferation
527
tumor suppressor genes
category of genes: responsible for curbing cell growth
528
preimplantation genetic diagnosis
screening of embryos that are produced through in vitro fertilization for the presence of genetic or chromosome abnormalities
529
cytogenetics
laboratory field involving the character-ization of chromosome structure and number
530
karyotyping
test used to examine the visual appearance of chromo-some structure and number
531
FISH
(Fluorescence in situ hybridization) utilized both for rapid detection of chromosome number and for targeting specific DNA sequences
532
pharmacogenomics
discipline that blends pharmacology with genomic capabilities
533
antisense oligonucleotide
(sequence of complementary nucleotides) is used to directly bind the DNA or RNA to block the aberrant gene product Imantinib
534
transcription factor modulators
selectively increase or decrease transcription levels of certain genes
535
GWAS
(Genome-wide association studies) genomic tests used in both research and clinical practice that were originally designed to identify relationships between common genome variation and particular traits of interest
536
lymphoma
hematolgic malignancies that originate in the lymphatic tissue
537
AML
(Acute myelogenous leukemia) 30% of cases
538
ALL
(Acute lymphocytic leukemia) 2/3 cases likely to be children
539
CML
(Chronic myelogenous leukemia)
540
CLL
(Chronic lymphocytic leukemia)
541
NHL
(Non-Hodgkin lymphoma)
542
Multiple myeloma
a group of B cells (plasma cells), these produce large amounts of antibodies
543
Multiple myeloma (causes)
not well understood obesity, toxin exposure, substance abuse, and genetic influence play a role
544
AML (cause)
unknown, but risk factors (not inherited) (1) chemotherapeutic treatment (2) ionizing radiation (3) long-term exposure to benzenes or other petroleum products (4) smoking those with down syndrome
545
AML (s/s)
depend on degree of pancytopenia (a lower-than-normal number of red and white blood cells and platelets in the blood) weakness and fatigue related to anemia, unresolved fever and fection related to neutrotpenia (inf: pneumonia, UTI, upper respiratory) bleeding issues (ecchymoses, petechiae, menorrhagia)
546
menorrhagia
heavy bleeding; menstrual bleeding that lasts more than 7 days
547
metrorrhagia
bleeding at irregular intervals, particularly between expected menstrual periods
548
menometrorrhagia
excessive and prolonged uterine bleeding occurring at irregular intervals
549
polymenorrhea
menstrual interval of less than 21 days
550
dysmenorrhea
severe mentral cramping
551
leukocytosis (s/s) w/ AML
(an abnormally elevated white blood cell count) headache, diplopia, cranial nerve palsies, and mental status changes
552
AML (Tx)
Restoring normal hematopoiesis is the goal systemic chemotherapy is the cornerstone (induction and consolidation)
553
AML complete remission is defined as
restoration of normal peripheral blood cell counts, maturation of all cell lines, and fewer than 5% blasts
554
ALL (causes)
can occur ant any age but considered to be particularly childhood malignant features of the leukemic cells: Morphologic (change in shape) cytochemical (change in biochemical properties) cytogenetic (change in genetic properties) immunologic (change in immunologic properties, such as surface proteins)
555
ALL is considered to be a clonal disease
(one in which all malignant cells derive from a single errant cell) via a progeny (initially transformed leukemic cell divides and passes on the alterations in genetic material to descendant cells)
556
ALL (s/s)
fever, bleeding, bone pain, and lymphadenopathy, but persist beyond treatment bone pain is common among children but if they refuse to bear weight uncommon: mediastinal mass which is concurrent with NHL, making it difficult to differentiate
557
ALL (Tx)
eradicate the malignant immature lymphoid cells and restore normal hematopoiesis induction and consolidation, but aimed at CNS (diff from AML)
558
CML (causes)
characterized by overproliferation of mature granulocytes exposure to high-dose radiation consistent with surviving an atomic bomb - direct result of a genetic alteration that results in aberrant cellular proliferation. (diff btwn AML) increased myeloid cell proliferation
559
CML (s/s)
asymptomatic; disease is frequently found during routine blood work thrombocytosis or thrombocytopenia symp: excessive sweating or night sweats, weakness and fatigue, splenomegaly, Acute gouty arthritis
560
CML (Tx)
normalizing the white blood cell count, eliminating immature myeloid cells chemo: hemotologic remission, difficult to achieve cytogenic tyrosine kinase inhibitors: target genetic defect material
561
CLL (cause)
overproduction of B cells prime in older (white) adults, asians have lowest rates split into Rai (US) and Binet (EU) stages trisomy 12 was the most common cytogenetic abnormality, 11,13,14 were 2nd most
562
CLL (s/s)
25% asymp. blood tests; spleno/hepatomegaly fever for 2 weeks w/o inf., night sweat, weight loss
563
CLL (Tx)
no known cure; determined by stage, aimed at restoring normal lymphocyte counts Chemotherapy is given to stop the cancer cells from progressing, and immunotherapy is used to stimulate the body’s own defenses in fighting the disease
564
NHL (cause)
heterogeneous group of malignancies that originate in the lymphatic system rates are higher in older individuals, classified on basis on cell lineage and maturity of malignant cells; rate of cell prolif. indolent/aggressive
565
indolent
(low grade tumor) grow slow and do not result in PT feeling symp.
566
aggressive
(high-grade tumor) grows fast and result in PT feelling symp
567
NHL (s/s)
enlarged lymph nodes is most common extranodal: commonly in GI, abdomin pain, swelling, loss of appetite; red patches A for absent, B for present
568
NHL (Tx)
depends on pathology, stage, and tumor, age comorbidity surgery, chemotherapy, radiation therapy, immunotherapy, stem cell transplant, and waiting
569
Multiple myeloma (cause)
characterized by the proliferation of malignant plasma cells toxin and hazardous chemical exposure, obesity, and possible genetic influence most common genetic: inactivation of tumor-suppressing genes
570
Multiple myeloma (s/s)
Anemia (normocytic or normochromic) is a common bone pain, and renal issues
571
Multiple myeloma (Tx)
combo: radiation and chemotherapy and often involves stem-cell transplantation ferrous supplementation, hydration and biphosphate to str. bone.; braces applied to back and extremities